You are here


Should PrEP be rolled out worldwide?

21 April, 2015

Despite its proven efficacy of pre-exposure prophylaxis in randomised controlled trials it is not widely implemented as an HIV prevention tool. With nearly two million new HIV infections last year it seems that the use of pre-exposure prophylaxis as a HIV prevention tool is not used to its full extent.


Rates of transmitted HIV drug resistance increased only slightly

15 April, 2015

Rates of transmitted HIV drug resistance have only increased modestly in low and middle income countries according to new research published in PLoS Medicine.


First successful use of synthetic antibodies against HIV in humans

10 April, 2015

Successful trail in humans with synthetic antibodies against HIV


Early uptake of HIV treatment has doubled in the UK

2 April, 2015

Early uptake of HIV treatment among people living with HIV in the UK has more than doubled over a five-year period between 2008 and 2011.


OST positively affects treatment adherence for people who inject drugs

1 April, 2015

People living with HIV who inject drugs have a 68% increase in the odds of refilling their antiretroviral treatment (ART) prescriptions after being exposed to opiate substitution therapy (OST).


Trial studies likely to fail if community not actively involved in study set up

27 March, 2015

A recently published study about the failure of the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial in the New England Journal of Medicine, argues that the negative outcome of the study was not associated with the non-effectiveness of the product, but the participants deceit and lack of compliance.


World TB Day: A call for greater integration of HIV and TB services

24 March, 2015

This World Tuberculosis (TB) Day, UNAIDS have called for a greater integration of HIV and TB services in order to combat the dual epidemics.


PET scan reveals hiding places of HIV

18 March, 2015

Newly developed scanning techniques make it possible to identify where latent HIV is hiding in the body. This new development will create better opportunities to eradicate HIV from the body. Antiretroviral treatment (ART) is able to eradicate HIV from the blood, but as the virus returns when people stop taking treatment, HIV must be hiding somewhere in the body.